Appointed by TheraCryf, an AIM-listed clinical stage drug development company focussing on oncology and neuropsychiatry to advise on its financial and investor communications as well as industry positioning and social media.
Appointed by TheraCryf, an AIM-listed clinical stage drug development company focussing on oncology and neuropsychiatry to advise on its financial and investor communications as well as industry positioning and social media.